![Page 1: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/1.jpg)
METAL IONS IN HEART DISEASE
Michael J. Davies
The Heart Research Institute
145 Missenden Road, Camperdown, Sydney, Australia
![Page 2: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/2.jpg)
The Heart Research Institute• Independent Research Institute • Opened in 1989• Bicentennial initiative of
– National Heart Foundation– Cardiologists of Royal Prince Alfred Hospital– NSW State Government
• Non-profit, registered charity• Affiliated to
– Royal Prince Alfred Hospital– University of Sydney
![Page 3: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/3.jpg)
HRI Research Groups
• Cell Biology (Ken Rodgers)
• Clinical Research (David Celermajer / Len Kritharides)
• Endothelial Cell Biology (Philip Barter)
• Free Radical (Mike Davies)
• Lipid Research (Kerry-Anne Rye)
• Molecular Biology (Alison Death)
• Vascular Immunology (Annemarie Hennessy)
![Page 4: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/4.jpg)
Mission statement
Develop new scientific knowledge which will lead to prevention, early detection and reversal of atherosclerosis (the cause of cardiovascular disease).
![Page 5: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/5.jpg)
What is atherosclerosis?• A process that clogs arteries with deposits of
cholesterol and lipids.
![Page 6: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/6.jpg)
What is atherosclerosis?• A process that clogs arteries with deposits of
cholesterol and lipids.
• This reduces the blood supply to the organ that the artery supplies, which can result in serious organ damage.
• Rupture of lesions can release particulate matter that blocks other blood vessels
![Page 7: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/7.jpg)
![Page 8: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/8.jpg)
Consequences of atherosclerosis
• Angina
• Heart attack (myocardial infarction)
• Stroke
• Intermittent claudication
• Gangrene
![Page 9: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/9.jpg)
The cost of atherosclerosis• Major health problem and cost to society
• 1 person dies every 10 minutes• 41% of all deaths arise as a result of atherosclerosis• Coronary heart disease is largest single cause of death
(more than 29,000/year)• Stroke second greatest killer (more than 12,000/year)• Atherosclerosis is a leading cause of long term disability
in adults• $3.7 billion a year (12% of health budget)
![Page 10: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/10.jpg)
Areas of expertise within HRI
• Lipid metabolism• Free radical chemistry and biochemistry• Stem cells• Cell signalling• Protein modification, metabolism and turnover• Cytokines• Endothelial cell function• Diabetes
![Page 11: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/11.jpg)
Specialised equipment / facilities
• Cell isolation and culture (primary and cell lines)
• Isolation and handling of lipoproteins (LDL / HDL)
• Enzyme kinetics and assays
• Quantification of DNA oxidation (HPLC, agarose gels)
• Quantification of normal and oxidised lipids and cholesterol
• Quantification of normal and oxidised / modified proteins (HPLC, 1D and 2D gel electrophoresis, proteomics)
• Quantification of antioxidants (HPLC, GC/MS)
• Radioactive tracer work
• Identification and quantification of radical formation (EPR, NO / O2 /H2O2 electrodes)
![Page 12: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/12.jpg)
Quantification of oxidised DNA bases
X.H2O
8-oxodG2’-deoxyguanosine
Presence of 8-oxodG disrupts base-pairing and gives G-C to A-T transversions
0
200
400
600
800
1000
1200
1400
Non-irradiated 1000 Gy 1500 Gy 2000 Gy Reduced
No added metal ions
+ Cu+
8-o
xo
dG
/ 1
05
par
ent
2'-d
G
(fro
m c
alf
thym
us
DN
A h
ydro
lysa
tes)
Histone H1
* o
* o
*
*
O
H
O
O
H
N
N
N
N
H
O
N
H
2
O
H
O
O
H
N
N
N
N
H
O
N
H
2
O
H
O
O
H
N
N
N
N
H
O
N
H
2
O
H
+.
![Page 13: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/13.jpg)
Specialised equipment / facilities
• Cell isolation and culture (primary and cell lines)
• Isolation and handling of lipoproteins (LDL / HDL)
• Enzyme kinetics and assays
• Quantification of DNA oxidation (HPLC, agarose gels)
• Quantification of normal and oxidised lipids and cholesterol
• Quantification of normal and oxidised / modified proteins (HPLC, 1D and 2D gel electrophoresis, proteomics)
• Quantification of antioxidants (HPLC, GC/MS)
• Radioactive tracer work
• Identification and quantification of radical formation (EPR, NO / O2 /H2O2 electrodes)
![Page 14: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/14.jpg)
Quantification of protein oxidation: measurement ofspecific side-chain oxidation products
Tyrosine DOPA
3-chlorotyrosine
3-nitrotyrosine
di-tyrosine
Phenylalanine o-, m-tyrosine
dimers
Tryptophan N-formylkynurenine,
kynurenine,
5-hydroxytryptophan,
7-hydroxytryptophan
Histidine 2-oxo-histidine
Glutamic acid hydroperoxides
Leucine hydroperoxides,
alcohols,
-ketoisocaproic acid,
isovaleric acid,
isovaleraldehyde,
isovaleraldehyde oxime,
carbonyl compounds.
Valine hydroperoxides,
alcohols,
carbonyl compounds.
Lysine hydroperoxides,
alcohols,
carbonyl compounds.
Proline hydroperoxides,
alcohols,
5-hydroxy-2-aminovaleric acid,
carbonyl compounds.
Arginine 5-hydroxy-2-aminovaleric acid
Isoleucine hydroperoxides,
alcohols,
carbonyl compounds
Glycine Aminomalonic acid
Methionine Methionine sulphoxide
Cysteine Cystine,
Oxy acids
![Page 15: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/15.jpg)
Quantification of oxidised proteins in tissue samples
Proteins extracted from tissue samples (normal and diseased),delipidated, and hydrolysed to free amino acids.
HPLC with UV, fluorescence and multi-channel electrochemical detection used to quantify both oxidised species and parent amino acids.
Results expressed as ratio of oxidised species to parent amino acid.
Radiometric and chemiluminescence detectors also available.
![Page 16: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/16.jpg)
Oxidised proteins are present in diseased human arteries
Proteins extracted from human artery samples (normal and advanced carotid lesions) delipidated, and hydrolysed to free amino acids, and analysed by HPLC. Results expressed as moles oxidised species / mole parent.Elevated levels of oxidised lipids and decreased antioxidant concentrations also detected.
0
400
800
1200
DOPA m-Tyr o-Tyr
Normal ArteryCarotid Plaque
0
100
200
300
400
di-Tyr Val.OH1 Leu.OH2
Fu et al, Biochem. J., 1998, 333, 519-525
![Page 17: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/17.jpg)
Specialised equipment / facilities
• Cell isolation and culture (primary and cell lines)
• Isolation and handling of lipoproteins (LDL / HDL)
• Enzyme kinetics and assays
• Quantification of DNA oxidation (HPLC, agarose gels)
• Quantification of normal and oxidised lipids and cholesterol
• Quantification of normal and oxidised / modified proteins (HPLC, 1D and 2D gel electrophoresis, proteomics)
• Quantification of antioxidants (HPLC, GC/MS)
• Radioactive tracer work
• Identification and quantification of radical formation (EPR, NO / O2 /H2O2 electrodes)
![Page 18: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/18.jpg)
Oxidation as a cause of atherosclerosis and its complications
• Oxidative events postulated to be important both in the initiation of atherosclerosis and in plaque rupture.
• Some evidence to support this hypothesis, but also considerable evidence for other factors being as, or more, important.
• Potential catalysts of oxidative damage:– Enzyme reactions (lipoxygenase, peroxidases, oxidases, heme
protein reactions)
– Activated inflammatory cells
– Nitric oxide / peroxynitrite
– Trace redox-active metal ions
![Page 19: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/19.jpg)
Oxidative modification model of atherosclerosis
LDL
LDL (bad cholesterol)
Vessel wall
Blood vesselWhite blood cells
LDL
LDL
LDLLDL
LDL
LDL
LDL
Endothelial cells
Oxidative modification of LDL particles
![Page 20: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/20.jpg)
Are trace metal ions present at elevated levels in lesions ?
Oxidants Protein oxidation
Lipid peroxidation
![Page 21: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/21.jpg)
Advanced Human Plaque
Healthy Human Intima
Iron signalOrganic radicals
Magnetic field (G)
Non-destructive technique of EPR spectroscopy used to examine presence of organic radicals and metal ions, particularly Fe(III) and Cu(II) in advanced human lesions.
EPR analysis of human lesions
![Page 22: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/22.jpg)
Correlation of iron levels detected by EPR and ICPMS with tissue status
Plaque Healthy Intima
0
1
2
SamplePlaque Healthy IntimaSmooth M
0
1
2
3
Sample
Mean iron values detected by EPR in lesions significantly higher than that detected in healthy intima samples.
Mean iron values detected by ICPMS in lesions significantly higher than that detected in healthy intima samples.
![Page 23: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/23.jpg)
Comparison of iron levels detected by EPR and ICPMS
0.0 0.5 1.0 1.5 2.0
0.0
0.5
1.0
nmol Fe(III)/mg tissue
Good correlation between the two measurements with EPR measuring ca. 70% of the total iron present
![Page 24: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/24.jpg)
Elevated levels of Cu detected in diseased intima samples compared to normal intima samples.
Cu(II) signals were not detected by EPR.
Plaque Healthy Intima Smooth M
0 .0 0
0 .0 1
0 .0 2
0 .0 3
0 .0 4
S am p le
ICPMS detection of copper in atherosclerotic lesions
![Page 25: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/25.jpg)
Correlation of metal ion levels with other parameters
• No correlation of metal ion levels with:
– Age of tissue donor
– Gender
– Protein levels in lesion
– Calcium levels in lesion
![Page 26: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/26.jpg)
Correlation of iron levels with cholesterol accumulation
EPR-detectable Fe(III) shows a positive correlation with cholesterol levels in lesions.
Is iron accumulation a cause or a consequence of cholesterol accumulation and hence lesion development?
Presence of elevated levels of non-heme, non-ferritin iron consistent with presence of elevated levels of protein and lipid oxidation products and depletion of antioxidants.
0 50 100 150 200 250
0
1000
2000
3000
4000
5000
nmol Fe(III)/mg protein
![Page 27: METAL IONS IN HEART DISEASE Michael J. Davies The Heart Research Institute 145 Missenden Road, Camperdown, Sydney, Australia](https://reader036.vdocument.in/reader036/viewer/2022062320/56649d4d5503460f94a2c127/html5/thumbnails/27.jpg)
Unanswered questions
• What are these Fe and Cu complexes ?• Where are they located :- intra- or extra-cellularly ?• Where do they come from ?
– Heme protein degradation ?possible role of oxidative damage or heme oxygenase
– Micro hemorrhage into plaques ?– Smooth muscle cell death ?
• Is it possible to modulate metal ion levels in the artery wall in vivo ?
• Does modulation of metal ion levels affect disease initiation, progression or plaque rupture
• Is it all a secondary artifactual event ?